cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Shattuck Labs Inc
7 own
9 watching
Current Price
$10.11
$0.09
(0.9%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
396.61M
52-Week High
52-Week High
11.11000
52-Week Low
52-Week Low
1.33000
Average Volume
Average Volume
0.16M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization396.61M
icon52-Week High11.11000
icon52-Week Low1.33000
iconAverage Volume0.16M
iconDividend Yield--
iconP/E Ratio--
What does the Shattuck Labs Inc do?
Shattuck Labs, Inc. is an innovative clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. We believe our approach has the potential to fundamentally transform the therapeutic modulation of the immune system. Shattuck Labs, Inc. corporate offices are located at 1018 W. 11th Street, Suite 100, Austin, Texas 78703 and 21 Parmer Way, Suite 200, Durham, North Carolina 27709 and our telephone number is (919) 864-2700. Our website is www.shattucklabs.com.
Read More
How much money does Shattuck Labs Inc make?
News & Events about Shattuck Labs Inc.
Benzinga
1 year ago
Latest Ratings for STTK DateFirmActionFromTo Apr 2021BerenbergInitiates Coverage OnBuy Jan 2021Evercore ISI GroupInitiates Coverage OnOutperform Nov 2020Cowen & Co.Initiates Coverage OnOutperform View More Analyst Ratings for STTK View the Latest Analyst Ratings read more...
Globe Newswire
1 year ago
CD20-targetedGADLEN demonstrated preclinical proof of concept of rapid B cell depletion in humanized mice and non-human primates, intended for clinical development in autoimmune disease AUSTIN, TX and DURHAM, NC, March 16, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a ...
Globe Newswire
1 year ago
AUSTIN, TX & DURHAM, NC, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune ...
Benzinga
1 year ago
Shattuck Labs (NASDAQ:STTK) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Shattuck Labs will report an earnings per share (EPS) of $-0.67. read more...
Business Wire
2years ago
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Shattuck Labs, Inc. (NASDAQ: STTK) on behalf of long-term stockholders following a class action complaint that was filed against Shattuck on February 11, 2022 with a...
Frequently Asked Questions
Frequently Asked Questions
What is Shattuck Labs Inc share price today?
plus_minus_icon
Can Indians buy Shattuck Labs Inc shares?
plus_minus_icon
How can I buy Shattuck Labs Inc shares from India?
plus_minus_icon
Can Fractional shares of Shattuck Labs Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Shattuck Labs Inc stocks?
plus_minus_icon
What is today’s traded volume of Shattuck Labs Inc?
plus_minus_icon
What is today’s market capitalisation of Shattuck Labs Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Shattuck Labs Inc?
plus_minus_icon
What percentage is Shattuck Labs Inc down from its 52-Week High?
plus_minus_icon
What percentage is Shattuck Labs Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.11
$0.09
(0.9%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00